CIK 0001907108
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Lexeo Therapeutics, Inc.
Sign in to watch- Ticker
- LXEO
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 854012572
- Phone
- +1 212-547-9879
- Business address
- 345 PARK AVENUE SOUTH, FLOOR 6, NEW YORK, NY, 10010
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-11-18 | Adler Eric Chief Medical Officer | Sale | −615 | $9.27 | $6K | 72,646 |
| 2025-10-17 | Adler Eric Chief Medical Officer | Sale | −3,344 | $8.94 | $30K | 73,299 |
| 2025-10-17 | Adler Eric Chief Medical Officer | Sale | −38 | $9.56 | $363 | 73,261 |
| 2025-10-15 | Adler Eric Chief Medical Officer | Grant or award | +9,570 | 76,643 | ||
| 2025-08-18 | Adler Eric Chief Medical Officer | Sale | −608 | $4.67 | $3K | 67,073 |
| 2025-05-16 | Adler Eric Chief Medical Officer | Sale | −585 | $2.77 | $2K | 67,681 |
| 2025-02-19 | Adler Eric Chief Medical Officer | Sale | −2,359 | $4.41 | $10K | 68,266 |
| 2025-01-07 | Adler Eric Chief Medical Officer | Grant or award | +43,750 | 70,625 | ||
| 2025-01-07 | Adler Eric Chief Medical Officer | Grant or award · Stock Option (right to buy) | +87,500 | 87,500 | ||
| 2024-02-02 | Adler Eric Chief Medical Officer | Grant or award | +26,875 | 26,875 | ||
| 2024-02-02 | Adler Eric Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +161,250 | 161,250 |
Page 1 of 1 · 11 trades